About
The Blood transfusion Genomics Consortium (BGC) is an international partnership between blood services, research institutions and industry leaders.
Our aim is to improve the safety and efficiency of blood and platelet transfusion by introducing cutting-edge genomics technology into routine clinical practice.
As part of the BGC, the national blood services of Australia, Canada, England, Finland, the Netherlands, New Zealand, Scotland, South Africa and Thailand, together with the New York Blood Center and Zurich Blood Transfusion Service work in partnership with academic hospitals in Boston, Cambridge, Greifswald, London and Milan, and Thermo Fisher Scientific to develop the DNA-based assays, software solutions, and infrastructure required to implement donor and patient genotyping on a global scale.
Members
The BGC has united several major blood services with leading academic hospitals and industry partners. Click below to find out more about our members.
Research
Our primary focus is to improve transfusion care for donors and patients by developing and using cutting-edge genomics technologies. Click below to view our research history and plans for the future.